DiSCIoser: Improving Arm Sensorimotor Functions After Spinal Cord Injury Via Brain-Computer Interface Training
Launched by I.R.C.C.S. FONDAZIONE SANTA LUCIA · Dec 1, 2022
Trial Information
Current as of January 22, 2025
Recruiting
Keywords
ClinConnect Summary
The DiSCIoser clinical trial is exploring a new way to help people recover hand movement after a spinal cord injury. This study focuses on patients who have experienced a cervical spinal cord injury within the past 30 to 90 days. The researchers are testing a special training program that uses a Brain-Computer Interface (BCI), which allows patients to think about moving their hands while the system helps them practice these movements. The goal is to see if this training can improve their ability to move their arms by encouraging the brain to adapt and change, a process known as plasticity.
To participate in this trial, individuals must be between 18 and 65 years old, have a certain level of hand movement ability, and have a specific type of spinal cord injury. They will undergo various assessments before and after the BCI training to measure any improvements. Participants should be aware that this trial is currently recruiting and aims to compare the BCI-based training with traditional training methods to see which is more effective for recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • subacute cervical SCI (30-90 days from event)
- • classification according to ISNCSCI AIS A-D, lesion level C1-T1
- • Upper Extremity Motor Score (UEMS) \< 40
- Exclusion Criteria:
- • other conditions (present or previous) potentially affecting sensorimotor upper limb function
- • inability to give informed consent and understand the requirements for the training
Trial Officials
Donatella Mattia, MD, PhD
Principal Investigator
Fondazione Santa Lucia, IRCCS
Giorgio Scivoletto, MD, PhD
Principal Investigator
Fondazione Santa Lucia, IRCCS
Febo Cincotti, MD, PhD
Principal Investigator
University of Roma La Sapienza
About I.R.C.C.S. Fondazione Santa Lucia
i.r.c.c.s. Fondazione Santa Lucia is a leading Italian research institute dedicated to advancing scientific knowledge in the fields of neuroscience, rehabilitation, and health sciences. As a clinical trial sponsor, the foundation is committed to conducting high-quality research aimed at improving patient outcomes and enhancing the understanding of neurological disorders. With a multidisciplinary team of experts and state-of-the-art facilities, Fondazione Santa Lucia fosters collaboration between researchers, healthcare professionals, and industry partners to translate innovative findings into effective therapeutic strategies and interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rome, , Italy
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials